James Knowles/PPTA
Nov 8, 2025, 11:21
PPTA’s James Knowles on Why a United Regulatory Strategy Benefits Industry and Patients
Plasma Protein Therapeutics Association (PPTA) shared on LinkedIn:
”When companies collaborate through a trade association, their voice is stronger.
Watch the video below to learn from PPTA’s James Knowles, Senior Director, Global Regulatory Policy, why a united regulatory strategy benefits the entire industry, and ultimately, the patients they serve.
Learn more.”
Stay updated with Hemostasis Today.
-
Jun 3, 2026, 14:44Brandy Seyller: Why Understanding the Coagulation Cascade Matters in Bleeding Cases
-
Jun 3, 2026, 14:33Anna Tobiasch: Should Fibrinogen and FXIII Be Restored Together After Severe Haemodilution?
-
Jun 3, 2026, 14:32Ifeanyichukwu Ifechidere: Coagulation Disorder or DOAC Interference?
-
Jun 3, 2026, 14:30Daniela Pachito: Honored to Present Four Research Posters at ISPOR 2026
-
Jun 3, 2026, 14:21Hemanth Kumar Manikyam: The Complex Immunology Behind Platelet Destruction in ITP
-
Jun 3, 2026, 14:07Satyadeep Dash: Why Calcium Is Critical to Effective Hemostasis
-
Jun 3, 2026, 13:51Ton Lisman: ISTH Opens Applications for Leadership Roles in Liver Disease Research
-
Jun 3, 2026, 13:41Abhishek Jain: New Microphysiological Model Sheds Light on COVID-19 Vascular Complications
-
Jun 3, 2026, 13:26M. Shujat Rasool: DVT Red Flags Every Clinician Should Know